Tirzepatide
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly · Phase 2 · Recruiting · Enrollment 1481
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| LY3305677 Obesity ISA OXA1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN01 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN02 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Obesity ISA MC01 | Obesity or overweight | n/r | n/r | n/r | n/r |